BMT — New Silkroutes Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareBalancedMicro Cap
2019 June 30th | 2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 0.357 | -7.77 | 0.457 | -47 | -7.62 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 1.41 | 11.8 | 0.693 | 46.1 | 7.02 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -8.32 | -0.404 | -7.53 | 2.75 | -1.92 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -5.51 | 6.59 | -2.9 | 5.97 | 0.456 |
Capital Expenditures | -0.224 | -0.15 | -2.56 | -0.708 | -0.621 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -15 | 0.061 | -0.875 | — | 6.69 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -15.2 | -0.089 | -3.44 | -0.708 | 6.07 |
Financing Cash Flow Items | 5.71 | 5.25 | -0.342 | -4.94 | -0.401 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 15.6 | 3.84 | -5.79 | -8.11 | -7.06 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -5.15 | 10.2 | -10.5 | -3.2 | -1.21 |